Pregnant women’s experiences and perceptions of participating in the EVERREST prospective study; a qualitative study

Lawn JE(2011)Stillbirths: where? When? Why? How to make the data count? Lancet. 377 1448-1463

Blencowe H(2014)Treatment of poor placentation and the prevention of associated adverse outcomes – what does the future hold? Prenat Diagn 34 677-684

Pattinson R(2012)Long-term increase in uterine blood flow is achieved by local overexpression of VEGF-A(165) in the uterine arteries of pregnant sheep Gene Ther 19 925-935

Cousens S(2014)Uteroplacental adenovirus VEGF gene therapy increases fetal growth velocity in growth-restricted sheep pregnancies Hum Gene Ther 25 375-384

Kumar R(2016)Maternal therapy with ad.VEGF-A165 increases fetal weight at term in a Guinea pig model of fetal growth restriction Hum Gene Ther 27 997-1007

Ibiebele I(2018)Perinatal and long-term effects of maternal uterine artery adenoviral VEGF-A165 gene therapy in the growth-restricted guinea pig fetus American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 315 R344-R353

Gardosi J(2017)Prediction of perinatal mortality for the midtrimester FGR fetus using ultrasound and angiogenic markers Br J Obstet Gynaecol 124 15-329

Day LT(2001)Empirically supported ethical research practice: the costs and benefits of research from the participants’ view Account Res 8 309-e485

Stanton C(2012)Deciding to join a perinatal randomised controlled trial: experiences and views of pregnant women enroled in the magpie trial Midwifery. 28 e478-642

Spencer RN(2014)The experience of pregnant women with a diagnosis of fetal lower urinary tract obstruction (LUTO) Midwifery. 30 636-559

Lawn JE(2011)Stillbirths: where? When? Why? How to make the data count? Lancet. 377 1448-1463

Blencowe H(2014)Treatment of poor placentation and the prevention of associated adverse outcomes – what does the future hold? Prenat Diagn 34 677-684

Pattinson R(2012)Long-term increase in uterine blood flow is achieved by local overexpression of VEGF-A(165) in the uterine arteries of pregnant sheep Gene Ther 19 925-935

Cousens S(2014)Uteroplacental adenovirus VEGF gene therapy increases fetal growth velocity in growth-restricted sheep pregnancies Hum Gene Ther 25 375-384

Kumar R(2016)Maternal therapy with ad.VEGF-A165 increases fetal weight at term in a Guinea pig model of fetal growth restriction Hum Gene Ther 27 997-1007

Ibiebele I(2018)Perinatal and long-term effects of maternal uterine artery adenoviral VEGF-A165 gene therapy in the growth-restricted guinea pig fetus American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 315 R344-R353

Gardosi J(2017)Prediction of perinatal mortality for the midtrimester FGR fetus using ultrasound and angiogenic markers Br J Obstet Gynaecol 124 15-329

Day LT(2001)Empirically supported ethical research practice: the costs and benefits of research from the participants’ view Account Res 8 309-e485

Stanton C(2012)Deciding to join a perinatal randomised controlled trial: experiences and views of pregnant women enroled in the magpie trial Midwifery. 28 e478-642

Spencer RN(2014)The experience of pregnant women with a diagnosis of fetal lower urinary tract obstruction (LUTO) Midwifery. 30 636-559